188 related articles for article (PubMed ID: 9024201)
1. Plasmodium chabaudi: immunogenicity of a highly antigenic glutamate-rich protein.
Wiser MF; Giraldo LE; Schmitt-Wrede HP; Wunderlich F
Exp Parasitol; 1997 Jan; 85(1):43-54. PubMed ID: 9024201
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites.
Scorza T; Grubb K; Cambos M; Santamaria C; Tshikudi Malu D; Spithill TW
Int J Parasitol; 2008 Jun; 38(7):819-27. PubMed ID: 18062974
[TBL] [Abstract][Full Text] [Related]
3. Towards a malaria vaccine: what is in sight?
del Giudice G
Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
[No Abstract] [Full Text] [Related]
4. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
5. Isolation of merozoite rhoptries, identification of novel rhoptry-associated proteins from Plasmodium yoelii, P. chabaudi, P. berghei, and conserved interspecies reactivity of organelles and proteins with P. falciparum rhoptry-specific antibodies.
Sam-Yellowe TY; Del Rio RA; Fujioka H; Aikawa M; Yang JC; Yakubu Z
Exp Parasitol; 1998 Jul; 89(3):271-84. PubMed ID: 9676705
[TBL] [Abstract][Full Text] [Related]
6. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
Amante FH; Crewther PE; Anders RF; Good MF
J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
[TBL] [Abstract][Full Text] [Related]
7. Plasticity of immune responses suppressing parasitemia during acute Plasmodium chabaudi malaria.
Weidanz WP; Kemp JR; Batchelder JM; Cigel FK; Sandor M; Heyde HC
J Immunol; 1999 Jun; 162(12):7383-8. PubMed ID: 10358190
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
9. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P
Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647
[TBL] [Abstract][Full Text] [Related]
10. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
11. Passive transfer of Plasmodium falciparum MSP-2 pseudopeptide-induced antibodies efficiently controlled parasitemia in Plasmodium berghei-infected mice.
Martínez PA; Yandar N; Lesmes LP; Forero M; Pérez-Leal O; Patarroyo ME; Lozano JM
Peptides; 2009 Feb; 30(2):330-42. PubMed ID: 19071172
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune responses to the Plasmodium falciparum antigen Pf155 RESA in adults with differential clinical conditions from an Indian zone where malaria is endemic.
Biswas S; Rao DN; Roy A; Yadav RP; Ghosh SK; Kabilan L
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):219-27. PubMed ID: 8629049
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.
Xu H; Hodder AN; Yan H; Crewther PE; Anders RF; Good MF
J Immunol; 2000 Jul; 165(1):389-96. PubMed ID: 10861076
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to a Plasmodium falciparum blood-stage antigen as a tool for predicting the protection levels of two malaria-exposed populations.
Astagneau P; Roberts JM; Steketee RW; Wirima JJ; Lepers JP; Deloron P
Am J Trop Med Hyg; 1995 Jul; 53(1):23-8. PubMed ID: 7542843
[TBL] [Abstract][Full Text] [Related]
15. Immunization of mice with Plasmodium TCTP delays establishment of Plasmodium infection.
Taylor KJ; Van TT; MacDonald SM; Meshnick SR; Fernley RT; Macreadie IG; Smooker PM
Parasite Immunol; 2015 Jan; 37(1):23-31. PubMed ID: 25376500
[TBL] [Abstract][Full Text] [Related]
16. Strain-specific immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the rodent malaria parasite Plasmodium chabaudi.
Cheesman S; Tanabe K; Sawai H; O'Mahony E; Carter R
Infect Genet Evol; 2009 Mar; 9(2):248-55. PubMed ID: 19121414
[TBL] [Abstract][Full Text] [Related]
17. Parasite-specific IgM plays a significant role in the protective immune response to asexual erythrocytic stage Plasmodium chabaudi AS infection.
Couper KN; Phillips RS; Brombacher F; Alexander J
Parasite Immunol; 2005 May; 27(5):171-80. PubMed ID: 15987340
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum: D260, an intraerythrocytic parasite protein, is a member of the glutamic acid dipeptide-repeat family of proteins.
Barnes DA; Wollish W; Nelson RG; Leech JH; Petersen C
Exp Parasitol; 1995 Aug; 81(1):79-89. PubMed ID: 7628570
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA.
Ahlborg N; Iqbal J; Björk L; Ståhl S; Perlmann P; Berzins K
Exp Parasitol; 1996 Mar; 82(2):155-63. PubMed ID: 8617342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
